Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons

Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: بهمن یوسفی , انصار کریمیان , محمد میرزا آقازاده عطاری

کلمات کلیدی: multidrug resistance, nanoparticles, natural products, physical approaches, RNA interference

نشریه: 16801 , 2 , 72 , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله بهمن یوسفی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات پزشکی مولکولی
کد مقاله 70820
عنوان فارسی مقاله Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
عنوان لاتین مقاله Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Multidrug resistance (MDR), defined as the ability of cancer cells to gain resistance to both conventional and novel chemotherapy agents, is an important barrier in treating malignancies. Initially, it was discovered that cellular pumps dependent on ATP were the cause of resistance to chemotherapy, and further studies have found that other mechanisms such as increased metabolism of drugs, decreased drug entry, and defective apoptotic pathways are involved in this process. MDR has been the focus of numerous initiatives and countless studies have been undertaken to better understand MDR and formulate strategies to overcome its effects. The current review highlights various nano-drug delivery systems including polymeric/solid lipid/mesoporous silica/metal nanoparticles, dendrimers, liposomes, micelles, and nanostructured lipid carriers to overcome the mechanism of MDR. Nanoparticles are novel gateways to enhance the therapeutic efficacy of anticancer agents at the target site of action due to their tumor-targeting abilities, which can limit the unwanted systemic effects of chemotherapy agents and also reduce drug resistance. Additionally, other innovative strategies including RNA interference as a biological process used to inhibit or silence specific gene expression, natural products as MDR modulators with little systemic toxic effects, which interfere with the functions of proteins involved in drug efflux, and physical approaches such as combination of conventional drug administration with thermal/ultrasound/ photodynamic strategies are also highlighted.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
بهمن یوسفیهفتم
انصار کریمیانپنجم
محمد میرزا آقازاده عطاریدوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
16.pdf1398/10/292614342دانلود